This is a non-financial technical announcement from a micro-cap company with a history of post-filing declines. No immediate trading catalyst — monitor for any subsequent partnership or funding news that could validate the platform commercially.
Price Chart
Executive Summary
SciSparc's majority-owned subsidiary NeuroThera announced successful internal validation of a proprietary quantum sampling workflow for clinical trial data analysis. The announcement is a technical milestone with no financial details, revenue, or near-term commercial impact, and the company's market cap is only $3M.
Key Facts
- NeuroThera (TSXV: NTLX), a majority-owned subsidiary of SciSparc, validated a proprietary quantum sampling workflow for clinical trial data analysis.
- The workflow uses a hybrid quantum-classical architecture (QMCMC) and was tested on an S&P 500 company's quantum computing platform.
- No financial terms, revenue, or commercial timeline were disclosed; the validation is an internal technical milestone.
Financial Impact
No financial figures disclosed; validation is a technical milestone with no stated revenue or cost impact.
Risk Factors
- No revenue or commercial adoption timeline provided; the platform remains early-stage.
- Micro-cap biotech with $3M market cap is highly speculative and prone to large price swings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3335231 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $1.29 | awaiting T+5 | — | $1.29 (−0.04%) |
Oct 23, 2026 4d ago | 6-K | $1.09 | awaiting T+5 | — | $1.29 (+18.35%) |
Oct 22, 2026 5d ago | Press Release | $1.20 | awaiting T+5 | — | $1.29 (+7.50%) |
Oct 15, 2026 11d ago | 6-K | $2.00 $1.20 | ▲ +40.00% | ▲ +38.99% | $1.29 (+35.50%) |
Oct 15, 2026 11d ago | 6-K | $2.00 $1.20 | ▼ −40.00% | ▼ −38.99% | $1.29 (−35.50%) |
Oct 15, 2026 12d ago | Press Release | $2.00 $1.20 | ▼ −40.00% | ▼ −38.99% | $1.29 (−35.50%) |
Oct 7, 2026 20d ago | 6-K | $4.64 $3.63 | ▼ −21.77% | ▼ −20.79% | $1.29 (−72.20%) |
Sep 30, 2026 26d ago | 6-K | $4.55 $4.43 | ▲ +2.64% | ▲ +3.94% | $1.29 (+71.65%) |
Sep 24, 2026 4w ago | 6-K | $5.39 $4.55 | ▼ −15.58% | ▼ −15.17% | $1.29 (−76.07%) |
Sep 23, 2026 4w ago | Press Release | $5.01 $4.72 | ▼ −5.79% | ▼ −5.11% | $1.29 (−74.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers